KATRINA MONTENEGRO: Open Payments
NPI 1629637426 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,713 in 93 payments from 18 companies in 2025. Trend: 2023 $1,582 · 2024 $2,970 · 2025 $2,713
Food & beverage: $2,559Education: $154
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $512 |
| UCB, Inc. | 14 | $479 |
| ABBVIE INC. | 16 | $288 |
| Janssen Biotech, Inc. | 11 | $236 |
| Arcutis Biotherapeutics, Inc. | 3 | $172 |
| Lilly USA, LLC | 4 | $168 |
| LEO Pharma Inc. | 2 | $142 |
| Organon LLC | 2 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $113 |
| GENZYME CORPORATION | 2 | $97 |
Products named: Bimzelx, TREMFYA, DUPIXENT, NEMLUVIO, Zoryve, EBGLYSS, ANZUPGO, VTAMA.
Industry payments across GA — which companies pay providers there.
